Featured Headlines Feed for GEVA Headlines for Synageva BioPharma http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic Synageva BioPharma™ to Present at the Goldman Sachs and Wells Fargo Healthcare Conferences http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/05/synageva-biopharma-to-present-at-the-goldman-sachs/.aspx DailyFinance Wed, 05 Jun 2013 07:50:14 GMT FDA Designation for Synageva Candidate - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99954/fda-designation-for-synageva-candidate.aspx Zacks Wed, 22 May 2013 21:20:01 GMT Synageva BioPharma™ to Present at the Jefferies 2013 Global Healthcare Conference http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/synageva-biopharma-to-present-at-the-jefferies-201/.aspx DailyFinance Wed, 22 May 2013 15:19:20 GMT Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/biotech-companies-see-insider-purchases-ceo-phillip-frost-increases-stake-in-opko-and-felix-baker-buys-acadia-cm247258.aspx Nasdaq Mon, 20 May 2013 11:20:00 GMT Synageva's Sebelipase Alfa Receives Breakthrough Therapy Designation for Early Onset LAL Deficiency http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3602961/synagevas-sebelipase-alfa-receives-breakthrough-therapy-designation-for-early-ons.aspx Benzinga Mon, 20 May 2013 07:34:14 GMT Synageva's Sebelipase Alfa Receives Breakthrough Therapy Designation from FDA http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3602806/synagevas-sebelipase-alfa-receives-breakthrough-therapy-designation-from-fda.aspx Benzinga Mon, 20 May 2013 07:07:35 GMT 3 Horrendous Health-Care Stocks This Week http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/3-horrendous-health-care-stocks-this-week-28/.aspx DailyFinance Sat, 18 May 2013 08:45:00 GMT Synageva BioPharma™ Joins the International MPS Network in Support of MPS Awareness Day 2013 http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/synageva-biopharma-joins-the-international-mps-net/.aspx DailyFinance Wed, 15 May 2013 07:20:45 GMT Synageva BioPharma Corp Enters Oversold Territory (GEVA) http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920214/1/synageva-biopharma-corp-enters-oversold-territory-geva.html.aspx?puc=aol&cm_ven=aol TheStreet Fri, 10 May 2013 12:35:00 GMT UPDATE: J.P. Morgan Downgrades Synageva BioPharma to Neutral on Challenges Ahead http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3579494/update-j-p-morgan-downgrades-synageva-biopharma-to-neutr.aspx Benzinga Fri, 10 May 2013 12:00:20 GMT Benzinga's Top Downgrades http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/downgrades/13/05/3578410/benzingas-top-downgrades.aspx Benzinga Fri, 10 May 2013 07:03:32 GMT Synageva BioPharma™ Announces One Year of Treatment Data with Sebelipase Alfa in Late Onset LAL Defi http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/synageva-biopharma-announces-one-year-of-treatment/.aspx DailyFinance Thu, 09 May 2013 07:20:31 GMT Synageva BioPharma™ Reports First Quarter 2013 Financial Results http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/synageva-biopharma-reports-first-quarter-2013-fina/.aspx DailyFinance Tue, 07 May 2013 17:00:24 GMT GEVA Crosses Below Key Moving Average Level http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11910968/1/geva-crosses-below-key-moving-average-level.html.aspx?puc=aol&cm_ven=aol TheStreet Wed, 01 May 2013 11:42:00 GMT Late Onset LAL Deficiency (CESD) Literature Review Published in the Journal of Hepatology http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/26/late-onset-lal-deficiency-cesd-literature-review-p/.aspx DailyFinance Tue, 26 Mar 2013 07:15:44 GMT Why Synageva BioPharma Shares Slumped http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/12/why-synageva-biopharma-shares-slumped/.aspx DailyFinance Tue, 12 Mar 2013 12:25:00 GMT UPDATE: Wedbush Raises PT to $55 on Synageva BioPharma on Valuation, First Patient ARISE Dose http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3409168/update-wedbush-raises-pt-to-55-on-synageva-biopharma-on-.aspx Benzinga Tue, 12 Mar 2013 12:15:26 GMT UPDATE: Piper Jaffray Lifts Synageva PT on Attractive Upcoming LAL-D Treatment http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3408361/update-piper-jaffray-lifts-synageva-pt-on-attractive-upc.aspx Benzinga Tue, 12 Mar 2013 09:39:39 GMT Synageva BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1264861-synageva-biopharma-s-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx Seeking Alpha Mon, 11 Mar 2013 23:04:03 GMT Synageva BioPharma™ Reports 2012 Full Year Financial Results http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/11/synageva-biopharma-reports-2012-full-year-financia/.aspx DailyFinance Mon, 11 Mar 2013 16:21:30 GMT